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Abstract
Aquaporin-1 (AQP1) is a water channel that is highly expressed in tissues with rapid O2 transport. It has been reported that
this protein contributes to gas permeation (CO2, NO and O2) through the plasma membrane. We show that hypoxia
increases Aqp1 mRNA and protein levels in tissues, namely mouse brain and lung, and in cultured cells, the 9L glioma cell
line. Stopped-flow light-scattering experiments confirmed an increase in the water permeability of 9L cells exposed to
hypoxia, supporting the view that hypoxic Aqp1 up-regulation has a functional role. To investigate the molecular
mechanisms underlying this regulatory process, transcriptional regulation was studied by transient transfections of mouse
endothelial cells with a 1297 bp 59 proximal Aqp1 promoter-luciferase construct. Incubation in hypoxia produced a dose-
and time-dependent induction of luciferase activity that was also obtained after treatments with hypoxia mimetics (DMOG
and CoCl2) and by overexpressing stabilized mutated forms of HIF-1a. Single mutations or full deletions of the three
putative HIF binding domains present in the Aqp1 promoter partially reduced its responsiveness to hypoxia, and
transfection with Hif-1a siRNA decreased the in vitro hypoxia induction of Aqp1 mRNA and protein levels. Our results
indicate that HIF-1a participates in the hypoxic induction of AQP1. However, we also demonstrate that the activation of
Aqp1 promoter by hypoxia is complex and multifactorial and suggest that besides HIF-1a other transcription factors might
contribute to this regulatory process. These data provide a conceptual framework to support future research on the
involvement of AQP1 in a range of pathophysiological conditions, including edema, tumor growth, and respiratory diseases.
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Introduction
During the last decade new functions, locations, and regulatory
pathways have been described for AQP1. Its canonical function as a
specific channel for water transport across cell membranes has
become wider and it has been suggested that it contributes to
transmembrane gas permeation (CO2, NO, NH3 and O2) in several
different cell types [1–4]. AQP1 is expressed in tissues with high rates
of gas transport, such as microvessel endothelium, alveolar
epithelium, and O2/CO2 sensing chemoreceptor glomus cells in
the carotid body and neonatal adrenal chromaffin cells [5,6].
Expression of AQP1 is now known to be associated with
inflammatory and neoplastic processes and has been detected in
response to mechanical injury in numerous cells and tissues, including
astrocytes, pneumocytes, lymphocytes, and several types of tumor cell
[7–12], in which its presence had not previously suspected. It is
known that expression of several AQPs in the central nervous system
(CNS) is altered by exposure to hypoxia and subsequent reoxygena-
tion [13], and that inhibition of Aqp1 expression using siRNA
significantly reduces hypoxia-inducible angiogenesis in cultures of
human retinal vascular endothelial cells [14].
Chronic hypoxia induces the expression of numerous genes by
activation of hypoxia-inducible transcription factors (HIF), mainly
HIF-1a and HIF-2a [15,16]. These transcription factors, stabi-
lized by hypoxia, play an essential role in numerous adaptive or
pathophysiological processes, such as erythropoiesis, glycolysis,
angiogenesis, inflammation and tumor progression, among others
[16,17]. Participation of HIF-1a in the transcriptional regulation
of some AQPs has recently been demonstrated [11,14,18,19]. For
instance, in the cerebellum of rats subjected to hypoxia,
increments in the mRNA and protein levels of vascular endothelial
growth factor (VEGF) and aquaporin-4 (AQP4) were found to be
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closely associated to an increase in HIF-1a expression. Increased
expression of AQP4 enhances water permeability of blood vessels
and contributes to explaining edema formation [20]. Consistent
with this, a direct correlation was observed between expression of
AQP4 and of VEGF and HIF-1a in glioma cells and peritumoral
edematous tissue [21]. In an ischemic/hypoxic model, traumatic
brain injury induces HIF-1a awhich, in turn, up-regulates
expression of AQP4 and AQP9. Additionally, inhibition of HIF-
1a by 2-methoxyestradiol reduced the up-regulated levels of both
these AQPs [18].
We have previously reported that hypoxia induces Aqp1 mRNA
expression [4], and it is also known that pathological situations
presenting tissue hypoxia stimulate the transcriptional expression
of AQP1 [4,11,14]. However, the molecular mechanism under-
lying these phenomena, in particular the direct participation of
HIF-1a, has not yet been established. In this paper, we study the
hypoxic regulation of the AQP1 gene and analyze in detail the role
of the Aqp1 promoter in this process. We have also investigated
the involvement of HIF-1a in Aqp1 modulation.
Materials and Methods
Ethics Statement
Animals were anesthetized by injection of 350 mg/kg chloral
hydrate and then sacrificed following the animal care protocols
approved by the local ethics Committee of Virgen del Rocio
University Hospital. Such protocols were described in detailed in
the grant proposal which led to the award of the funding used to
perform the present study, and were approved on April 2008 by
Dr Cisneros as president of the Ethics Committee of the Virgen
del Rocı´o University Hospital (act of approval Nu 4/2008). In all
the experiments, animals were cared for in accordance with the
European guidelines (Directive 86/609/EEC).
Cell Line and Culture Conditions
Rat gliosarcoma cells (9L) were kindly provided by Dr M.J.
Merrill [22]. These cells were cultured in Dulbecco’s Modified
Eagle Medium (DMEM; GIBCO-BRL) with 4.5 g/L glucose,
4 mM L-glutamine and pyruvate supplemented with 10% fetal
calf serum (GIBCO-BRL) and maintained at 37uC and in 5%
CO2. The endothelial murine cell line (EOMA cells, ATCC
catalog no.: CRL-2586) derived from a mixed hemangioendothe-
lioma was cultured at 37uC and 10% CO2 in DMEM with 4.5 g/
L glucose, supplemented with 4 mM L-glutamine and 10% fetal
bovine serum (BioWhittaker, Belgium). Primary cultures of
pulmonary artery smooth muscle cells were obtained following
previously described protocols [23].
Plasmid Construction for Reporter Assays
The firefly luciferase reporter plasmid pXP2 (kindly provided by
Dr J.A. Pintor-Toro [24]) was used to assess the promoter activity of
the 59-flanking region of the mouse AQP1 gene. An Aqp1 promoter
construct 21297/21 (P-AQP1) was generated by standard PCR
from mouse genomic DNA using specific primers (S: 59-
GGTCTTTACTCGGGATTTTG-39 and AS: 59-GCTGGC-
AGGGACCTCGACTTA-39) and first cloned into the pCR2.1
(Invitrogen, CA) vector, and then transferred by restriction with
KpnI and XhoI into the pXP2 vector. The ,1.3 Kb Aqp1
promoter-luciferase construct was digested by restriction enzymes to
obtain smaller constructs. Restriction with SmaI, with SmaI/BbvCI
and with SmaI/StuI produced the 2650/21, the 2266/21 and
the 2122/21 constructs respectively. For nucleotide mutations of
the three putative HIF binding sites (HBS) (CGTG) present on the
,1.3 Kb promoter the QuickChange Site-Directed Mutagenesis
Kit (Stratagene, CA) and the primers indicated in the Supplemen-
tary Table S1 were used. Mutations were confirmed by sequencing
(Eurofins MWG, Ebersberg, Germany).
Transient Transfection and Luminescence Assay
The day before transfection, EOMA cells were plated at
1.36105 cells/ml on 35-mm culture dishes, using DMEM culture
medium without antibiotics and half the amount of serum. For
transfection, 5 ml of Lipofectamine 2000 (Invitrogen) and 1 mg of
the Aqp1 promoter-luciferase constructs were mixed in 500 ml of
Opti-Mem (Invitrogen), together with 100 ng of pRL-TK vector
(Promega, USA) to normalize for transfection efficiency. Trans-
fection was allowed to proceed for 6 h and then the medium was
replaced by complete DMEM. After overnight incubation, cells
were left in normoxia or incubated in hypoxia prior to luciferase
activity assays. When deleted constructs of the promoter were
transfected, equimolar ratios of DNA with respect to the 1.3 Kb
promoter were maintained using the pCDNA3 (Invitrogen) empty
vector. In co-transfection experiments of Aqp1 promoter with
mutated Hif-1a or Hif-2a DNA vectors (kindly provided by Dr
C.W. Pugh and Dr C. Simon, respectively) [25,26], 1 mg of each
DNA was used. As control, 1 mg of the promoterless pXP2 vector
was transfected or untransfected cells were used. The pH3SVL
vector (kindly provided by Dr R. Wenger) [27] a modified pGL3b
(Promega, WI) firefly luciferase plasmid with six Hif Binding Sites
(HBS), was used as control for positive response to HIF (data not
shown). Luciferase activity was measured with the GloMaxTM 96
microplate luminometer (Promega) using the commercial Dual-
Luciferase Reporter Assay System (Promega), according to
manufacturer’s instructions. Promoter luciferase activity was
normalized against the renilla activity from pRL-TK vector.
RNA Extraction and Reverse Transcription – Quantitative
PCR (RT-qPCR) Analysis
TRIzol reagent (Invitrogen) was used following the manufac-
turer’s protocol. The reverse transcription reaction was performed
using the SuperScript II RNase H2 Reverse Transcriptase Kit
(Invitrogen). Quantitative PCR analysis was performed in an ABI
Prism 7500 Sequence Detection System (Applied Biosystems,
Warrington, UK) using SYBR Green PCR Master Mix (Applied
Biosystems) and the thermocycler conditions recommended by the
manufacturer. Cyclophilin RNA was amplified to normalize for
the amount of RNA used. Primers were designed using the Primer
Express software and the corresponding sequences are indicated in
the Supplementary Table S2. Melting curve analysis showed a
single sharp peak with the expected Tm for all samples.
Hypoxia Treatments
Experiments performed to measure Aqp1 promoter activity by
Luciferase reporter assay and to evaluate stabilization of HIF-1a
protein were carried out in a sealed anaerobic glove-box (COY
Laboratory Products, MI) with O2 maintained at 1–2%. Mice were
kept either under normal conditions or in a hypoxia chamber (COY
Laboratory Products) at 10% O2 for 48 hours. Animals were
anesthetized by injection of 350 mg/kg chloral hydrate and then
sacrificed following the animal care protocols approved by our
institution. Tissue samples were collected for later RNA extraction.
In Situ Hybridization
Whole brains were dissected and fixed overnight at 4uC in 4%
(wt/vol) paraformaldehyde in PBS. After fixing, brains were
washed in PBS. In situ hybridization was performed on 30- to 50-
mm thick slices cut with a Lancer vibratome as previously
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described [28]. Sense and antisense digoxigenin-UTP-labeled
riboprobes against mouse Aqp1 were synthesized from pGEM-T
Easy vector containing a partial cDNA sequence (737 bp) of the
gene, using SP6 or T7 RNApolymerase respectively. After
hybridization, slices were incubated with alkaline phosphatase-
conjugated anti-digoxigenin antibody (1:1000; Roche, Mannheim,
Germany). Photographs were taken with a Provis microscope
(Olympus, Tokyo, Japan) with Nomarski optics.
Western blot analysis
Cells at ,80% confluence were washed with cold PBS,
scrapped and collected in 1 ml of cold PBS and centrifuged at
1656 g for 5 min at 4uC. For protein extraction, each pellet was
lysed in 150–300 ml of homogenization buffer as previously
reported [4]. Proteins (10 mg) were resolved by SDS-PAGE
(6%) for HIF-1a analysis and after electrophoresis were transferred
onto Hybond-P PVDF membranes (Amersham Biosciences, NJ)
using the Novex transfer system (Novel Experimental Technology,
CA). Membranes were probed overnight with 1:500 anti-HIF-1a
(Cayman Chemical, MI) and 1:5000 anti-b actin (Abcam, UK) as
primary antibodies and after washing they were incubated for
2 hours with the corresponding anti-IgG horseradish peroxidase
secondary antibodies. The immunoreactive bands were developed
with the ECL PLUS Western Blot Detection System (GE
Healthcare, USA) and visualized using a Typhoon 9400
phosphorimager (Amersham Biosciences).
Immunocytochemistry
Cells were plated on poly L-lysine coated coverslips. After
incubation in hypoxic or normoxic conditions, they were washed
with PBS and fixed for 10 min with 3% paraformaldehyde at
room temperature. Cells were then permeabilized with triton
0.1% in PBS (PBTx) for 5 min and blocked for 2 hours with 10%
fetal calf serum and 1 mg/ml BSA in PBTx before incubation
overnight at 4uC with the primary antibody. Rabbit polyclonal
anti-AQP1 at 1:500 dilution (Abcam) was used, followed by the
two-step EnVision+Dual Link System-HRP (DakoCytomation,
Denmark), a staining technique using goat anti-rabbit immuno-
globulins conjugated to a peroxidase-labeled polymer and DAB
substrate/chromogen solution, to produce a brown precipitate.
Samples were counter-stained with hematoxylin and slides were
mounted in 50% glycerol in PBS with 0.02% sodium azide in
mounting medium (DakoCytomation). Sections were photo-
graphed using an AX70-Olympus microscope equipped with an
Olympus DP10 camera.
Water Permeability Measurements
Osmotic water permeability (Pf) was measured in suspensions of
freshly suspended cells with or without hypoxia treatment, by
stopped-flow light-scattering spectroscopy. Stopped-flow experi-
ments were performed on a temperature-controlled Hi-Tech
Scientific PQ/SF-53 spectrometer system (TgK Scientific, UK),
which has a 2-ms dead time, and is interfaced with an 80386 IBM
PC/AT-compatible microcomputer. Experiments were performed
at temperatures ranging from 10uC to 32uC. Typically, five runs
were stored and analyzed in each experimental condition. After
the hypoxia or normoxia treatment, cells were detached from the
flasks by incubation in PBS containing 20 mM EDTA for 15 min.
Cells were then washed twice with PBS and suspended at a density
of 1.56103 to 3.56103 cells/mm3. Cell suspensions were mixed
with an equal amount of hyperosmotic solution (PBS containing
300 mM mannitol) to reach an inwardly directed gradient (150
mOsM) of the impermeant solute. Cell shrinkage due to water
efflux causes an increase in scattered light intensity. The kinetics of
cell shrinkage were assessed in terms of variation in the intensity of
the light at 400 nm scattered at 90u [29] until the light signal
stabilized. The Pf was estimated by fitting the scattered light signal
with a double exponential function and using the linear
relationship between Pf and the weighted average rate constant
kde obtained from the expression kde = (DI1k1+DI2k2)/DI1+DI2),
where DI1 and DI2 correspond to the changes in signal with a slow
or a fast rate constant, k1 or k2, respectively. Pf (cm s
21) was
calculated from the equation Pf = kde (Vo/A)(1/Vw(osmout)‘) where
Vo/A is the cell volume to area ratio, Vw is the molar volume of
water and (osmout)‘ is the final medium osmolarity after the applied
osmotic gradient. All solution osmolarities were determined from
freezing point depression on a semi-micro osmometer (Knauer,
Germany). Standards of 100 and 400 mOsM were analyzed prior
to samples, which were measured in triplicate.
Activation Energy Evaluation
Water permeability was measured at five different temperatures
ranging from 10uC to 32uC. The activation energy (Ea) of water
transport was calculated from the slope of the Arrhenius plot (lnPf
as a function of 1/T) multiplied by the gas constant R.
Cell Volume Measurements
Equilibrium cell volumes were obtained by phase contrast
microscopy using an inverted microscope (Axiovert Zeiss 100 M)
equipped with a digital camera. Cells were dislodged with PBS-
EDTA solution, washed and resuspended in PBS. For each set of
data measured, an aliquot of cell suspension was placed on a
microscope slide and an average of 6 images was taken with 4–6
cells in each. Cells were assumed to have a spherical shape with a
diameter calculated as the average of the maximum and minimum
dimensions of each cell.
Statistical analysis
Data were presented as mean 6 standard error of the mean
(SEM), and were analyzed with either the paired Student’s t-test or
one-way analysis of variance (ANOVA) followed by Tukey’s,
Student-Newman-Keuls or Fisher’s tests. All statistical calculations
were performed using SigmaStat 2.03 for Windows. P values
considered significant are marked with asterisks: P#0.05 with one
asterisk (*), P#0.01 with two asterisks (**) and P#0.001 with three
asterisks (***).
Results
Molecular and Functional Induction of AQP1 by Hypoxia
We have previously shown that Aqp1-mRNA expression in rat
lungs is induced by the exposure of animals to hypoxia (10% O2)
for 24 hours [4]. To determine whether this induction by hypoxia
was a general phenomenon, similar experiments were performed
in mice and in cultured cell lines. The RT-qPCR analysis
confirmed that expression of Aqp1 increased by about 2.6- and
2.0-fold in mouse lung and brain respectively, after exposure to
mild hypoxia (10% O2) for 48 hours (Figure 1A). Induction of
vascular endothelial growth factor (Vegf), a well-established
hypoxia-responsive gene, was analyzed as control. Although no
induction of this gene was detected in lung tissue, it was observed
that Vegf was induced faster than Aqp1 in brain tissue, indicating
that expression kinetics of the two genes are different in this organ
(Supplementary Figure S1A). Expression of Aqp1 in the lung
mainly occurs in endothelium and vascular smooth muscle. In
primary cultures of isolated rat pulmonary arterial myocytes
hypoxia caused Aqp1 and VEGF to increase by,1.5 and 2.5-fold,
respectively (Supplementary Figure S1B). In situ hybridization
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analysis showed that within the brain up-regulation of Aqp1 RNA
was clearly detected in epithelial cells of the choroid plexus
(Supplementary Figure S1C).
To gain further insight into the consequences of Aqp1 induction
by hypoxia, we performed experiments in 9L cells, a glioblastoma
cell line in which up-regulation of Aqp1 mRNA by hypoxia has
Figure 1. Hypoxic up-regulation of Aqp1 in vivo. (A) RT-qPCR analysis showing induction of Aqp1 and Vegf mRNA in lung and brain of mice
exposed to hypoxia (10% O2 for 48 h, Hy) with respect to normoxia (48 h at 20% O2, Nx). (B) RT-qPCR analysis showing induction of Aqp1 and Vegf
mRNAs in the glioblastoma (9L) cell line incubated in hypoxic (1% O2 for 24 h) or normoxic conditions. All values were normalized to the normoxic
levels of mRNA and are presented as means 6 SEM (N$3), *P#0.05, **P#0.01, *** P#0.001. (C) Representative western blot analysis of AQP1 in
normoxic cells or after 24 and 48 h of hypoxic treatment (1% O2) and a summary of quantification data obtained from at least 3 independent
experiments (N = 3). b-actin was used as control for protein loading. (D) Immunohistochemistry assay of AQP1 expression in 9L cells kept under
normoxic conditions or exposed to hypoxia (1% O2 for 48 h). Brown immunostaining indicates the presence of AQP1; nuclei were stained with
hematoxylin.
doi:10.1371/journal.pone.0028385.g001
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also been reported [22]. Exposure of 9L cells to hypoxia (1% O2)
for 24 to 48 hours resulted in a marked up-regulation of Aqp1
expression at mRNA and protein levels. Analysis by RT-qPCR
showed more than a 5-fold induction of Aqp1 mRNA after
24 hours of hypoxic treatment, and, as expected, up-regulation of
Vegf (,6-fold) was also observed (Figure 1B). Importantly, higher
expression of Aqp1 protein following hypoxia was also confirmed
by western blot analysis (,2.3-fold after exposure to hypoxia for
48 hours) (Figure 1C) and by immunocytochemistry (Figure 1D).
To determine whether the hypoxia-induced Aqp1 protein was
functional, plasma membrane water permeability of normoxic and
hypoxic 9L cells was assessed using stopped-flow light-scattering.
Figure 2A shows a typical recording of normalized scattered light
intensity obtained in suspended 9L glioma cells subjected to an
osmotic gradient of 150 mOsM/l with mannitol. As described
above, the change in light scatter due to cell shrinking was fitted
with a double exponential function in order to calculate Pf.
Equilibrium cell volumes, Vo, measured for both normoxic and
hypoxic cells were 1135.166.4 and 2227.2611.4 mm3 respec-
tively. A representative Arrhenius plot using Pf measurements at
five different temperatures from which the Ea for water transport
was calculated is shown in Figure 2B. Pf in hypoxia-treated AQP1
induced cells (19.363.4 cm s21) was about 2.5-fold greater than in
normoxic cells (7.961.3 cm s21) at 10uC, a temperature at which
the lipid bilayer contributes less to the bulk permeability thus
enabling the functional detection of water channels (Figure 2). The
Ea value of 13.49 kcal mol
21 obtained for normoxic cells is high
and similar to the Ea for simple lipid membranes where no
channels facilitate water transport, whereas a lower Ea of
7.44 kcal mol21 obtained for hypoxic cells clearly suggests a
larger contribution of molecular channels for water permeation
[30]. Specifically, the higher Pf and lower Ea obtained are
compatible with the finding that exposure of 9L glioma cells to
hypoxia enhances AQP1 expression with a consequent increase in
membrane water permeability.
Transcriptional Activation of AQP1 Gene by Hypoxia is
HIF-1a-Dependent
To investigate the molecular bases underlying the hypoxic
regulation of Aqp1, we performed bioinformatic analysis of the
,1.3 Kb promoter region proximal to the initiation codon ATG
of Aqp1 (see Supplementary text), looking for the presence of
putative DNA binding sites for transcription factors. Several
consensus sites for transcription factors involved in regulation by
hypoxia of different genes, namely AP1, EGRF, CREB, ETSF,
SP1 and NFKb [31], were found. More significantly, however, we
identified the presence of three ‘‘XCGTG’’ or ‘‘HIF binding sites
(HBS)’’ corresponding to the reported consensus binding sequence
for HIF (hypoxia-inducible factor), located at positions 21105,
21044 and 2157 bp (Supplementary Figure S2),
To analyze Aqp1 regulation by hypoxia, a reporter vector was
constructed (P-AQP1) fusing the PCR generated mouse Aqp1
promoter (,1.3 Kb) to the firefly luciferase gene. Functional
response of the Aqp1 promoter was assessed in terms of the
luciferase activity observed upon transfection in a murine
hemangioendothelioma cell line (EOMA). Luciferase activity
derived from Aqp1 promoter activation increased in hypoxia
compared to normoxia in a time-dependent manner (Figure 3A),
and was higher at 1% than at 3% O2 (results not shown). These
findings demonstrated a clear response of the Aqp1 promoter to
hypoxic conditions and suggested the involvement of HIF in this
process. We also analyzed the effect on Aqp1 promoter activity of
the hypoxia mimetics CoCl2 and DMOG, which inhibit the prolyl
hydroxylases and, therefore, prevent HIF hydroxylation and its
proteasomal degradation [15,32]. Luciferase activity of the Aqp1
promoter construct measured after 24 hours of treatment was
found to be significantly increased by 100 mM CoCl2 (.2-fold)
and by 1 mmol/L DMOG (.4-fold), and even more by hypoxia
(.7-fold) (Figure 3B). No changes in basal luciferase activity were
observed when the promoterless construct (pXP2) was expressed as
control. These results strongly indicated that HIF-1a is involved in
the hypoxic up-regulation of Aqp1. Promoter-dependent luciferase
activity was also evaluated by co-transfecting cells with the
mutated forms of Hif-1a and Hif-2a (HIF-1a mut, HIF-2a mut),
which are resistant to normoxic prolyl-hydroxylation and
subsequent degradation [25,26]. Transfection of HIF-1a mut,
but not HIF-2a mut, produced significant induction (.3-fold) of
luciferase activity in normoxic EOMA cells (Figure 3C), thus
confirming the direct participation of HIF-1a in the hypoxic up-
regulation of Aqp1 promoter.
In parallel with Aqp1 promoter activation, in EOMA cells
hypoxia induced a clear stabilization of HIF-1a (Figures 3D–3F).
The HIF-1a level reached a peak after 4 hours of hypoxia
treatment and gradually decreased over the following 24 hours
(Figure 3D). Incubation in CoCl2 and DMOG over the same
period of time (Figure 3E) also stabilized HIF-1a but to a lesser
extent than hypoxia. Moreover, levels of HIF-1a due to co-
expression of HIF-1a mut in cells kept in normoxic conditions
were clearly higher than those observed in untransfected or
pcDNA3 transfected cells (Figure 3F).
Down-regulation of HIF Reduces Hypoxic Induction of
Endogenous AQP1 Expression
To investigate the involvement of HIF-1a in the in vitro hypoxia-
induced Aqp1 expression in 9L cells, we performed experiments
knocking down HIF-1a with specific siRNA. The experimental
protocol followed in these experiments is shown in Figure 4A.
Cells were co-transfected with 50 nM of specific or scramble
siRNA and, after 24 hours of transfection, they were either kept in
normoxic or incubated in hypoxic conditions for an additional
48 hours. First, the specificity and efficiency of the interference
was confirmed by RT-qPCR analysis of mRNA levels (Figure 4B)
and by western blot analysis of HIF-1a stability (Figure 4C). About
60% inhibition of Hif-1a mRNA expression was observed in cells
treated with specific siRNA when compared to scramble-treated
cells, whereas no effect was detected on Hif-2a or Aqp1 mRNA
expression (Figure 4B). Likewise, stability of HIF-1a protein after
hypoxic treatment (4 hours at 1% O2) was significantly diminished
(,50%) by specific interference compared to levels measured in
scramble-treated cells (Figure 4C). We were, therefore, able to
conclude that the Hif-1a siRNA used here was specific and
effectively reduced expression of this gene. The next step was to
analyze the effect that down-regulation of Hif-1a had on the
hypoxia-induced overexpression of endogenous Aqp1. In 9L cells
treated with Hif-1a siRNA and incubated in hypoxia for 24 hours,
levels of Aqp1 mRNA determined by RT-qPCR were 30% lower
than those in scramble-transfected cells (Figure 4D). Similarly,
levels of Aqp1 protein after 24 and 48 hours of Hif-1a interference
were also reduced compared to controls (Figure 4E). These results
strongly suggested the involvement of HIF-1a in the mechanism of
hypoxia-induced AQP1 expression in vivo.
Mutation and Deletion Analyses of the Aqp1 Promoter
To determine the actual contribution of HIF-1a to hypoxic
activation of the Aqp1 promoter, the three putative HBS identified
in the mouse promoter by analysis in silico were deleted by site-
directed mutagenesis either separately (MUT1, MUT2 and
MUT3) or all at the same time (T-MUT) (Figure 5A). Luciferase
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activity of these constructs in response to hypoxia was measured.
Mutations in the first (MUT1) or the third (MUT3) HBS (located
at positions 21105/21109 bp and 2157/2161 bp, respectively)
resulted in a reduction (,15%) in luciferase activity in response to
hypoxia when compared to the activity shown by the wild type or
non-mutated Aqp1 promoter (P-AQP1) (Figure 5B). By contrast,
mutation of the HBS located at position 21044/21048 bp
(MUT2) had no effect on the promoter response to hypoxia
(Figure 5B). In the triple mutant hypoxia-induced promoter
activity diminished by ,33%, this reduction being equivalent to
the sum of the individual effects produced by MUT1 and MUT3
separately (Figure 5B). These results indicated that at least two of
the three HBS present in the Aqp1 promoter participate in HIF-
mediated regulation of the AQP1 gene.
As an alternative approach to assess whether the HBS mutations
explored above did indeed decrease hypoxia induction of the
promoter by preventing the binding of HIF-1a and not other
transcription factors, we investigated whether the capacity of the
triple mutant to respond to HIF-1a mut, rather than hypoxia, was
also diminished. Luciferase activity of the two promoters, wild type
and triple mutant, was induced in normoxia by co-expression of
HIF-1a mut. The level of induction in the triple mutant promoter
Figure 2. Effect of hypoxia on the water permeability of 9L cells. (A) Normalized scattered light intensity obtained from stopped-flow
experiments at 10uC in suspended 9L cells subjected to an osmotic gradient of 150 mOsM/l with mannitol. Cells were pre-exposed in normoxic or 1%
O2 conditions for 48 h before these experiments. The time course of volume change after the osmotic shock was fitted with a double exponential to
calculate Pf. (B) Temperature dependence of water transport. Typical Arrhenius plots of water efflux from cells maintained in normoxia or treated in
hypoxia are shown. From the slope of these plots the activation energy (Ea) for water transport in 9L cells was calculated. Pf and Ea values were
obtained from at least three independent experiments.
doi:10.1371/journal.pone.0028385.g002
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was only half that observed in the wild type promoter (Figure 5C).
These results suggested that HIF-1a binds directly to the HBS on
the promoter and that this interaction is prevented in mutated
HBS, thus decreasing the transcriptional response to hypoxia.
On the other hand, using restriction enzymes, we progressively
shortened the length of the promoter region, from the longest
fragment of 1297 bp to shorter ones of 650, 267 and 122 bp in
which only one or none of the HBS remained (Figure 6A). As
control, luciferase activity of untransfected cells or transfected with
empty pXP2 or pXP2 with short fragments of 93, 63 and 33 bp
containing the TATA box region were analyzed. The luciferase
activity in response to hypoxia for all deleted forms of the
promoter was evaluated and compared to the wild type promoter
in simultaneous experiments in which equimolar concentrations of
Figure 3. Stabilization of HIF1a- induced transcriptional activity of the Aqp1 promoter. (A) A construct (P-AQP1) in which the reporter
firefly luciferase gene was driven by the mouse Aqp1 promoter was transfected into EOMA cells and incubated in normoxia or hypoxia at 1% O2, for
24 or 48 h. The values expressed in arbitrary units represent the ratios of firefly luciferase activity normalized by renilla luciferase activity (firefly/
renilla). (B) Relative luciferase activity measured in EOMA cells transfected with P-AQP1 and exposed to hypoxia (1% O2), normoxia (21% O2), or
normoxia plus hypoxia mimetics (CoCl2 [100 mM] or DMOG [1 mM]) for 24 h. (C) Relative luciferase activity measured from EOMA cells cotransfected
with P-AQP1 and mutated forms of HIF1/2a (HIF1/2a mut). Empty pcDNA3 plasmid was used as loading cDNA for control experiments. Cells
transfected with the empty vector (pXP2) were used as negative control. Values are expressed in arbitrary units as means6 SEM (n$3). ** P#0.01, ***
P#0.001. (D) Western blot time-course analysis of HIF1a protein in EOMA cells kept in normoxia or exposed to hypoxia (1% O2) for 2, 4, 12 and 24 h.
(E) Analysis by western blot of HIF1a protein in EOMA cells after 4 h with CoCl2 (100 mM) or DMOG (1 mM) treatments. (F) Western blot analysis of
HIF-1a protein levels in normoxic EOMA cells after 16 and 24 h of transfection with HIF-1a mut plasmid. Non-transfected cells and those transfected
with empty pcDNA3 vector were used as controls. b-actin served as protein loading control.
doi:10.1371/journal.pone.0028385.g003
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Figure 4. Inhibition by Hif-1a siRNA of Aqp1 mRNA and protein expression. (A) Schematic diagram of the protocol used in the Hif-1a siRNA
experiments. Samples were preincubated for 24 h with 50 nmol/L of either Hif-1a siRNA or scramble siRNA. (B) After 24 h of interference, mRNA
levels of Hif-1a, Hif-2a or Aqp1 were analyzed by RT-qPCR. (C) Hypoxic conditions (1% O2) were applied, and 4 h later, the levels of HIF-1a protein
were analyzed by western blot. Levels were quantified from three independent experiments (N= 3). (D), After 48 h (24 h of Hif-1a interference and
24 h of hypoxia) mRNA levels of Aqp1 and Vegf were analyzed by RT-qPCR and normalized by values determined with the scramble siRNA. (E) A
representative western blot showing levels of Aqp1 protein in cells treated with Hif-1a siRNA or with scramble siRNA after 48 h in hypoxia. Results of
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DNA for all constructs were cotransfected. As shown in Figure 6B,
the transcriptional response to hypoxia of the promoter 650-P-
AQP1 was reduced by 17% with respect to the wild type
promoter. This reduction fits very well with the 15% inhibition of
luciferase activity observed in MUT3, given that, as demonstrated
before, the second HBS (21044/21048 bp) mutated in MUT2
does not contribute to the response to hypoxia. Therefore, the first
HBS (21105/21109) is a functional binding site for HIF-1a. The
smaller promoter 267-P-AQP1, although conserving the same
HBS (2157/2161) present in 650-P-AQP1, showed a 39%
inhibition with respect to the wild type promoter, which suggested
the presence of other transcription factors (such as SP-1, EGR-1 or
NFKb) with possible binding sites on the deleted region that also
participate in the hypoxic response (Figure 6B). Finally, the
construct 122-P-AQP1 in which the remaining HBS was lost,
showed not only a dramatic fall in the response to hypoxia but,
more importantly, its basal luciferase activity almost disappeared
indicating an overall loss of transcriptional activity (Figure 6B).
These results support the view that HIF-1a participates in the
hypoxic up-regulation of mouse Aqp1, by binding to two of the
three HBS (one at 21044/21048 and the other at 2157/
2161 bp). However, other hypoxia-inducible transcription factors
with binding sequences present on the small remaining fragment
three western blot experiments (N= 3) are summarized here. b-actin was used as protein loading control. Values are presented as means 6 SEM
(n = 4). * P#0.01, ** P#0.001.
doi:10.1371/journal.pone.0028385.g004
Figure 5. Functional analysis of putative HIF Binding Sites
(HBS) in the Aqp1 promoter. (A) The three CGTG sites present in P-
AQP1 were individually mutated to AAAG (MUT1, MUT2 and MUT3) by
site-directed mutagenesis. The three sites were mutated at once on the
triple mutant (T-MUT). (B) Wild type (P-AQP1) or mutated constructs
were transfected into EOMA cells and incubated for 24 h either in
normoxic (21% O2) or at 1% O2 conditions before luciferase activity
measurements. Values are presented as means 6 SEM (N= 4). (C)
Relative luciferase activity measured from EOMA cells cotransfected
with either P-AQP1 or T-MUT together with HIF-1a mut or pcDNA3
empty plasmid. Cells were maintained under normoxic conditions for
24 h. Values are presented as means 6 SEM (N = 5)* P#0.05,
***P#0.001.
doi:10.1371/journal.pone.0028385.g005
Figure 6. Deletion analysis of the Aqp1 promoter. (A) Schematic
diagram of different-size reporter constructs indicating length of the
Aqp1 promoter (P-AQP1). (B) Relative luciferase activity measured in
EOMA cells transfected with the different constructs and exposed to
normoxia or hypoxia (1% O2) for 24 h. One-way analysis of variance
(ANOVA) followed by Fisher’s LSD test was used to evaluate the
statistical significance of differences. Bars represent the mean6 SEM for
N=3 independent experiments. *P#0.05, ** P#0.01, *** P#0.001.
doi:10.1371/journal.pone.0028385.g006
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of 267-P-AQP1 also seem to participate in the AQP1 gene up-
regulation upon exposure to low oxygen conditions.
Discussion
In the present work, hypoxic induction of AQP1 is shown in
several different mouse tissues and cell lines. A functional
correlation between hypoxic induction of AQP1 and increases in
water permeability is indicated here for the first time, and the
involvement of the hypoxia-inducible transcription factor HIF-1a
in this phenomenon is analyzed in detail.
Functional Implications for the Hypoxic Induction of
AQP1
Up-regulation of Aqp1 expression by hypoxia was demonstrated
in lung and brain tissue of mice exposed to 10% O2 for 24 and
48 hours. The increment in Aqp1 mRNA was within the range of
the values observed for other hypoxia-inducible genes in vivo,
although in the lung Aqp1 up-regulation was even higher than that
detected for Vegf, used as positive control. Hence, these results
suggest an important, previously unreported role for AQP1 in the
physiological response to hypoxia of these two organs. Identifica-
tion of lung cells over-expressing AQP1 under hypoxia was not
attempted in the present work. Nonetheless, related research from
our laboratory has indicated changes in the expression pattern of
AQP1 in lungs of patients with pulmonary diseases that can cause
severe hypoxemia, such as cancer and interstitial lung disease [12].
In situ hybridization analysis in brain tissue confirmed the
exclusive location of Aqp1 mRNA in choroid plexus epithelium
as previously described [33] and, furthermore, demonstrated that
over-expression of this gene by hypoxia was predominantly
detected in this tissue. It is well known that choroid plexus cells
are responsible for the formation of most of the cerebrospinal fluid
(CSF) and, further, it has been indicated that the Aqp1 protein
participates in CSF secretion, as well as in the modulation of
normal values of intracranial pressure [34–36].
The results of our stopped-flow light-scattering experiments are
consistent with participation of a hypoxic Aqp1 up-regulation in
the increase in water permeability observed under such conditions,
though further experiments are needed to confirm this. Further, it
seems likely that AQP1 is involved in pulmonary or brain edemas
produced by hypoxic events, such as those observed in acute
mountain sickness [37] or in cerebral ischemia due to vascular
injury. Hypoxic induction of AQP1 could also explain the over-
expression of this protein observed in several types of human
tumors [7–12], in which its presence has been always associated
with vascular angiogenesis [38] and the rapid water transport
necessary for migration and proliferation of new blood vessels
[38,39]. In the case of poorly oxygenated tumors, an increment of
Aqp1 expression in the vicinity would explain the typical
edematous area surrounding the tumor. Hence, for many of these
pathological situations in vivo reduction of Aqp1 expression, such as
that produced by blocking the transcription factor TTF1 [40] or
by inhibiting the JNK signaling pathway [41], might have a useful
therapeutic effect.
HIF-1a-Dependent Hypoxic Up-regulation of the Aqp1
Gene
Promoter analysis of the mouse AQP1 gene confirmed
transcriptional up-regulation by hypoxia as indicated by the in
vivo experiments described before. The promoter activity induced
by hypoxia was time- and dose-dependent as occurs with other
genes whose expression is modulated by O2 concentration
[15,42,43]. Our in depth analysis of the promoter-luciferase
construct has demonstrated that stabilization of the HIF-1a
protein, by cobalt chloride and DMOG [15,32], induces its
transcriptional activity. Induction was also observed by transfec-
tion with a mutated HIF-1a form resistant to prolyl hydroxylation-
dependent degradation. The lack of response to HIF-2a indicates
a very selective regulatory mechanism and supports the view that
HIF-1a participates in the hypoxic induction of the Aqp1 gene.
The results of our siRNA experiments strongly support the idea of
HIF-1a having a functional role in vivo in Aqp1 up-regulation by
hypoxia. Specifically, selective reduction of native Hif-1a dimin-
ished hypoxia-dependent induction of endogenous Aqp1 expres-
sion at both mRNA and protein levels, confirming direct
participation of HIF-1a in that regulatory process.
Moreover, inhibition of promoter activity when the three
putative HIF binding sites (CGTG) were mutated provides further
evidence for direct binding of HIF-1a but, given the incomplete
abrogation of the hypoxia response, also implies the involvement
of additional elements in this regulatory mechanism. The fully
normal response shown by the MUT2 promoter could well
indicate an inactive HBS for Hif-1a binding. It must be noted,
however, that as a result of this mutation one specific site for the
binding of AP1, a transcription factor also regulated by hypoxia
[31], appeared on the promoter offering an alternative explanation
for the unexpected result. The smallest hypoxia-responsive unit
found on the Aqp1 promoter corresponds to a short region before
the first ATG (2267/21 bp). Our in silico analysis of this region
revealed, in addition to a HIF-1a binding site (2157/2161 bp),
the presence of consensus sequences for binding of hypoxia-
responsive transcription factors such as EGR1, SP1, ETS1, AP1,
CREB1 and NFkb. Hence, it is possible that some of these
transcription factors participate together with HIF-1a in the
hypoxic activation of Aqp1. Indeed, cooperation between HIF-1a
and other transcription factors has been established in the hypoxic
regulation of several genes [31,44–46]. In line with the lung Aqp1
up-regulation reported here, is well known that AP1, SP1 and
CREB are selectively activated in pulmonary hypoxia [17] and
could be part of the hypoxic response of AQP1. Furthermore,
CREB activation by cAMP and binding of this to HBS [47,48] in
the Aqp1 promoter may constitute an alternative explanation for
transcriptional regulation of AQP1 by cAMP [49,50].
In conclusion, the present work demonstrates that expression of
the AQP1 gene is induced in hypoxia by a HIF-1a-dependent
mechanism. However, the mutational analysis of the Aqp1
promoter also suggests that besides HIF, other elements contribute
to the hypoxic regulation of the AQP1 gene. This observation is
important because it could indicate that in genes, such as Aqp1,
robustly modulated by hypoxia, multiple transcription factors may
participate in this adaptive response. Our study strongly supports
the idea that up-regulation of AQP1 by hypoxia may result in
increased membrane water permeability. Moreover, it provides a
mechanistic framework for understanding the augmented expres-
sion of AQP1 associated with tumors and might potentially explain
certain cases of edema associated with tissue hypoxia.
Supporting Information
Figure S1 Hypoxic up-regulation of Aqp1 in animal tissues and
culture cells (A), RT-qPCR analysis showing induction of Aqp1 and
Vegf mRNA in lung and brain of mice exposed to hypoxia (10%
O2 for 24 h, Hy) with respect to normoxia (24 h at 20% O2, Nx).
(B), RT-qPCR analysis showing induction of Aqp1 in primary
culture of rat pulmonary artery smooth muscle cells incubated for
24 h at 3% O2. All values were normalized to normoxic levels of
mRNA and are presented as means 6 SEM (N$3). *P#0.05,
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**P#0.01, ***P#0.001. (C), Analysis by in situ hybridization of
Aqp1 mRNA in choroid plexus cells of mice exposed to normoxia or
hypoxia (8% O2) for 48 h (N = 3).
(TIF)
Figure S2 Schematic diagram of the Aqp1 gene. (A), In silico
analysis of murine AQP1 gene indicated that it is constituted by
one transcript of 12.12 Kb with four exons separated by three
different introns. Three possible HBS (N A/G/TCGTG), the
TATA box and the translation start site (A+1TG) are indicated
over the 1297pb Aqp1-promoter. Numbers are relative to the
translation start site. (B), Bioinformatic analysis of AQP1 promoter
revealed the presence of DNA binding sites for distinct
transcription factors that have been implicated in regulation by
hypoxia of different genes, such as AP1, CREB, EGRF, ETSF,
HIF, NFKb, P53 and SP1.
(TIF)
Text S1 Bioinformatic analysis of Aqp1 promoter sequences.
(DOC)
Table S1 Primers to generate Aqp1 promoter mutants.
(DOC)
Table S2 Primers used for qPCR in mouse and rat samples.
(DOC)
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